The compound KSK-74 significantly compensates for metabolic disturbances that accompany obesity (plasma triglyceride, resistin, and leptin levels), improves glucose tolerance, and protects against adipocyte hypertrophy. This evidence concerns the gene RETN and obesity due to melanocortin 4 receptor deficiency.